Pfizer, Amgen, Johnson & Johnson, others fall on the US market amid Trump's US pharmaceutical tariff fear | Einsmark news

US Markets Today: The shares of the pharmaceutical sector fell at Wall Street Open on Wednesday, April 9, following fear of the upcoming US tariffs on pharmaceutical import investors amid a raging trade war between the United States and other world countries. Stock such as Pfizer, Amgen, Johnson & Johnson and Eli Lilly & Co. was, among other things, that opened lower after the US stock market opened on Wednesday. Pharma Stocks Pfizer Inc. Shares are currently trading 2.56 percent lower at $ 21.31 from 10:11 hours (EDT), compared to $ 21.84 on the previous US market. The shares opened lower at $ 21.11 by piece. Johnson & Johnson shares trade 2.37 percent at $ 146.45 after opening lower at £ 142.20, compared to $ 150 on the previous market. Amgen shares trade 2.48 percent lower at $ 273.23 in the early market session on the Nasdaq index, compared to $ 280.26 in the previous closure. The stock opened at $ 268.91 on Wall Street. Eli Lilly & Co. Shares were more than 3 percent at $ 701.25, compared to $ 726.24 in the previous closure. The stock trades lower than the $ 704.40 opening level at Wednesday’s early market session. Merck & Co. Inc. Shares have also dropped more than 3 percent, currently trading at $ 76.61, compared to $ 78.95 in the previous closure. The multinational pharmaceutical company’s shares opened at $ 76.76. Wall Street opened the Dow Jones Industrial Average (DJIA) 0.68 percent lower at 37,387,91 points today at 09:30 (EDT), compared to 37,645,59 points on the previous stock market. The Dow trades 0.14 percent higher in the early market session on Wall Street with 37.708 points. The S&P 500 index fell 0.35 percent to open at 4,965,28 points, compared to 4,982,77 points on the previous stock market. The index is currently trading 0.52 percent higher on Wall Street. The technical heavy Nasdaq-composed index scored 0.18 percent to 15,295.441 points, compared to 15.267.91 points on the previous market. The New York-based index traded 1.5 percent higher in the early market session, showing MarketWatch data. Trump Pharma tariffs Donald Trump announced on Tuesday, April 8, that the United States will soon impose a ‘big’ tariff for pharmaceutical imports in the Western country amid the ongoing tariff war. “We’ll tarip our pharmaceutical products … We’re going to announce a big tariff about pharmaceutical products soon,” President Donald Trump said in his speech. So far, the pharmaceutical sector has been exempt from the rates announced last week, but now, as the US plans to impose a duty on the import of drugs in the country, investors have become cautious about pharmaceutical shares in the US. Pharma businesses worldwide depend on the supply of their raw materials from foreign countries, and American major pharmaceutical businesses are no exception. Disclaimer: The views and recommendations above are those of individual analysts or brokerage companies, and not of currency. We advise investors to check with certified experts before making investment decisions.